Interleukin (Il)-12 is a heterodimeric cytokine composed of 35 and 40 kD chains that plays a key role in the induction
Introduction
Immune responses are regulated by many cellular and molecular interactions. A number of immunological effector functions are mediated by the cytokine interleukin (IL)-12, including polarization of T cells towards the Th1 phenotype.
1 Th1 cells are characterized by secretion of interferon-␥ (IFN-␥), and they mainly promote cellmediated immunity able to eliminate intracellular pathogens and the synthesis of complement-fixing antibody isotypes. IL-12 plays a major role in cell-mediated immunity against a variety of pathogens by its ability to induce rapidly the production of IFN-␥ not only from T cells but also from NK cells. 1 Because of this capacity, IL-12 is also important in the pathogenesis of many Th1-mediated autoimmune diseases.
ively expressed by many cell types. IL-12p40 exists both as a monomer and as the disulphide linked homodimer IL-12(p40) 2 , and both forms are produced in excess over IL-12p75. 5, 6 The IL-12p40 homodimer binds to the ␤1 subunit of the IL-12 receptor but is unable to mediate the biological actions of IL-12p75. [7] [8] [9] It is therefore a potent antagonist of bioactive IL-12 and could play a role in immune regulation.
Recently, we defined the genomic organization of IL12B, the human gene encoding IL-12 p40, and conducted an extensive search of polymorphisms within this gene. 10 We have also shown that allele 1 of IL12B is in strong linkage disequilibrium with the type 1 diabetes susceptibility gene (T1D), IDDM18. 11 The non-obese diabetic (NOD) mouse is a well-characterized animal model of T1D (reviewed in Yoshida and Kikutani 12 ). In these mice, the transition from a passive insulitis to an inflammatory, beta-cell destroying response is preceded by a rapid upregulation in the expression of IL-12p40 mRNA in pancreas and spleen cells. 13 In view of the importance of IL-12p40 in the regulation of the immune response, and in T1D in particular, we sequenced the cDNA from Il12b of the NOD mouse and compared it with the published IL-12p40 sequences, which are exclusively from the C57BL/6 strain. 3, 14 We found polymorphisms in the IL-12p40 sequence shared by NOD and other autoimmune-prone strains, one of which resulted in an amino acid substitution that caused the loss of an epitope recognized by a monoclonal antibody. We also observed allele-specific effects on basal and stimulated production of IL-12p40.
Results
Sequence comparison of NOD and B6 Il12b cDNAs RNA purified 15 from spleens of lipopolysaccharide (LPS)-treated NOD mice was reverse transcribed, amplified with appropriate primers and the resulting PCR products were sequenced. A comparison of the NOD/Lt sequence with the published B6 sequence is shown in Figure 1 . Two base changes (both T → C) were found, and both resulted in amino acid substitutions. One of these was derived from exon 5, and gave rise to a methionine (M) → threonine (T) substitution at residue 169 of the full-length molecule. The other change, resulting from a mutation in exon 7, would cause the NOD protein sequence to have a leucine residue at position 294, where the B6 sequence has a phenylalanine. A further change (G → A) from the published B6 cDNA sequence 3 would not result in an amino acid replacement. However, it should be noted that the reported B6 genomic sequence 14 also differs from this B6 cDNA sequence 3 but is the same as NOD in having an A at this position, so the reported cDNA sequence may be incorrect. Sequence of the NOD cDNA was determined from exon 1 to exon 7, and compared with the B6 cDNA sequence. 3 The start codon is underlined. The three differences from the B6 sequence are underlined and the two coding changes (both T → C) are also indicated with an asterisk. Sequences corresponding to the primers used for amplifying the NOD cDNA are in italics. The NOD exon 7 and 8 sequences were determined from additional amplification products from genomic DNA.
Strain distribution of Il12b alleles
To test whether any other mouse strains had the same alleles as NOD, a strain survey was performed. The T → C change in exon 7 resulted in the creation of a HhaI site. This formed the basis for a PCR-based definition of Il12b alleles. Of the inbred strains tested, BALB/c, B6, CBA, DBA/1 and NOR all lacked the HhaI site (Table 1a) . Strains with the same allele as NOD included the SJL strain, which was previously shown to share alleles at many loci with NOD, 16 as well as the autoimmune-prone NZB and NZW and their related strains NZO and NZC. AKR, A.SW and DBA/2 mice also shared the same exon 7 allele as NOD.
Direct sequence analysis of exon 5 PCR products showed that all the latter strains, with one exception, also shared with NOD the C allele, encoding threonine at this position (Table 1b ). The A.SW strain was found to have the exon 5 T allele, typical of B6 and other strains which lack the exon 7 HhaI site (Table 1c) The exon 5 alleles were determined by direct sequencing; the exon 7 polymorphisms were detected after HhaI digest of PCR products. IL12b haplotypes were defined on the basis of both exon 5 and exon 7 polymorphisms. levels of IL-12p40 were determined in the serum of untreated mice, showing allele-dependent variation between strains. Most IL12b b strains exhibited two-fold higher basal levels of IL-12p40 than did NOD mice and other strains carrying the IL12b a allele (Figure 2 ), suggesting that cis-acting elements of the IL12b a allele regulate basal IL12b expression. All the autoimmune-prone mice tested, NOD, (NZW×B)F1, SJL, and DBA/1 had a basal level of IL-12p40 around 150 pg/ml. In contrast, the nonautoimmune prone strains, BALB/c, B10.BR, B10.D2, C57BL/6 and C3H had a basal level of IL-12p40 around 300 pg/ml. The only exception among the IL12b b strains was DBA/1, which had a lower basal level of IL-12p40; it may be significant that autoimmune arthritis can be induced in this strain. 17 We next examined IL-12 serum levels following LPS administration. NOD mice produced significantly lower levels, compared to B6 mice, of IL-12p40 at early time points (1.5 and 3 h) after LPS administration ( Figure 3a) . However, the peak levels of IL-12p75, measured 6 h after LPS administration, were similar in both strains ( Figure 3b) . Il12b mRNA appears to be expressed at similar or higher levels in spleens of 3-h LPS-treated NOD and B6 mice, as judged by RT-PCR experiments ( Figure 4 ). In the experiment shown, NOD mice had twice the levels of Il12b expression, after standardization for ␤-actin expression.
Structural differences of IL-12p40 allelic forms recognized by specific mAbs
In early experiments examining IL-12 expression in NOD mice, we found no detectable IL-12 after LPS stimulation using a commercially available assay (Quantikine) (Figure 5a ). Both the above assays and another commercially available assay (PharMingen, San Diago, CA, USA) revealed that IL-12p40 from both NOD and B6 was in fact readily detectable after LPS stimulation (Figure 3) . Therefore, sequence change(s) in the NOD IL-12p40 prevented binding to antibodies in the Quantikine assay. This company would not provide any details of the anti- ) of six mice/group. **P Ͻ 0.005 by Mann-Whitney U test. IL-12p40 levels were determined by two-site ELISA, using MAb 10F6 for capture followed by biotin-conjugated goat anti-IL-12. IL-12p75 levels were determined by two-site ELISA, using MAb 9A5 for capture followed by 10F6-POD. bodies in its kit which, quite obviously, is unsuitable to measure IL-12 in NOD mice or indeed in other strains which bear the same Il12b alleles. The strain distribution of Il12b alleles allowed a unique opportunity to map the epitope recognised by the monoclonal antibody in the Quantikine kit. Since the A.SW IL12p40 sequence differs from all other strains by only a single amino acid, the ability of this kit to detect it would allow definition of the residue critical to epitope formation. IL-12p40 production was therefore measured in A.SW mice. As shown in Figure 5b , A.SW IL-12p40 was detected at the same level as in the B6 mice. This suggests that the single amino acid difference (M → T) between A.SW and NOD mice is crucial to the formation of a serologically-defined structure on the IL-12p40 molecule. In addition to its potential effect on the structure of IL12p40, the M → T change may also create an O-linked glycosylation site. If so, glycosylation of the threonine residue may not only block monoclonal antibody binding but may also have effects on the function of NOD IL12p40. However, the prediction algorithm NetGlyc2.0 predicted no glycosylation at Thr169 while the YinOYang server was equivocal, predicting a possible O-linked glycosylation above the first, but not second, threshold level.
To visualize the effects that the M → T change may have on IL-12 structure, a molecular model was calculated for each allelic form. The C-alpha backbone of the p40 domain is shown in Figure 6a . Both substitutions are surface residues and would not be expected to cause significant perturbations in the fold. The connolly surface (1.4 Angstrom probe) reveals both sites are solvent accessible and are able to participate in protein-protein interactions (Figure 6b ). The methionine resides on an exposed helix which has a deep depression on either side with aromatic residues forming a pocket. The threonine substitution does not perturb the geography of the molecular surface or the arrangement of the nearby side chains, leaving the context of the antibody binding site essentially unchanged (Figure 6c ), suggesting that the methionine residue itself is crucial to the epitope recognised by the allele-specific MAb. The volume of the side chain is significantly reduced with the threonine substitution and the polar nature of the side chain would be expected to cause a rearrangement of the associated solvation layer, which would have implications for antibody binding.
Discussion
We defined three variants that could affect the mouse IL12p40 protein. The allele represented by the published mouse cDNA sequence was found in many mouse strains, such as B6, BALB/c, CBA, and DBA/1. It was also found in the NOR strain, which has segments of B6 and DBA/2-derived chromosome regions on the NOD background; the NOR proximal mouse chromosome 11 containing segments derived from all of these strains. 18 The genotype data indicate that the region immediately surrounding Il12b in the NOR strain was derived from B6. Although they share most of their genome with NOD, NOR mice do not develop diabetes. 18 It may be significant that these two strains differ in their Il12b alleles, given the importance of the product of this gene in regulating diabetes susceptibility. 2, 12, 13 It was quite striking that all other autoimmune-prone strains tested, including NZB, NZW, and SJL, with the exception of DBA/1, also shared the same Il12b allele as NOD.
The third variant in mouse IL-12p40 differs in a single amino acid from the other two allelic forms. This rare allele probably arose from a cross-over or gene conversion event between exons 5 and 7 in an ancestor of the A.SW strain. The alternative explanation of a mutation event that changed the same nucleotide in exon 7 from T to C seems less likely but could be tested if further polymorphisms were to be found in the intervening introns of Il12b and by examining these in the presumptive ancestral and A.SW strains. The genetic heterogeneity observed in the three alleles of mouse IL-12p40 we have defined contrasts with the apparent lack of commonly occurring structural variants in human IL-12p40. 11 The fact that the monoclonal antibodies tested here differ in their ability to bind to NOD-and B6-derived IL12p40 strongly suggests that there is a structural differ- ence in these proteins. The loss of binding to NOD IL-12 by the Quantikine Mab could be explained by a combination of two effects of the threonine substitution. A reduction in side-chain volume would lead to a corresponding reduction in the contact area of the binding pocket of the antibody. Secondly, the introduction of an unpaired hydrogen bond donor/acceptor into a presumably hydrophobic pocket would incur an energetic cost of disrupting any associated ordered water network, which would further reduce antibody affinity.
Multiple sites of interaction between IL-12 and its receptor 7 have been demonstrated but the identity of the residue(s) of mouse IL-12p40 involved in this interaction are unknown. It is possible that the M → T substitution which results in a serologically defined change may also alter the binding affinity for IL-12p40 and its receptor. The structural change has the potential to affect receptor binding not only of IL-12p40 monomer and/or homodimer, but also of IL-12p75, or of the IL-12 p40 and p35 subunits to each other. Such differences may have important functional consequences for the regulation of immune responses in NOD and other autoimmune-prone strains. For example, they could affect the efficiency of signal transduction via the IL-12 receptor or modulate the regulatory role of the IL-12p40 homodimer, by augmenting or preventing its interaction with the IL-12 receptor ␤1 chain and consequently the biological action of the IL-12p75 heterodimer. No T1D susceptibility gene has as yet been mapped to the vicinity of Il12b in backcrosses of NOD mice with B6 19, 20 or F2 crosses to NOR. 18 For example, the Idd4 gene 19 is on mouse chromosome 11 but was mapped to a region over 20 cM distal to the reported location 14 of Il12b. However, the B6 backcrosses would not have detected a NOD-dominant gene effect, while in the NOR crosses a potentially protective effect of the NOR allele may not be sufficiently strong to be detected in the presence of all the other susceptibility alleles shared between the NOD and NOR strains. Furthermore, studies that have shown the ability of IL-12(p40) 2 to suppress diabetes development in NOD mice 21, 22 utilised the recombinant form derived from B6 rather than NOD. The implications of these studies may need to be re-evaluated if either of the two amino acid replacements identified here would be found to affect binding of IL-12p75 or IL-12(p40) 2 to the IL-12 receptor.
Recently, it was shown that macrophages from prediabetic NOD mice display elevated IL-12p75 production in vitro, probably due to enhanced expression of p40 mRNA. 23, 24 The closely-related NOR strain 18 did not show such elevated expression. Since NOD and NOR mice differ in their Il12b coding sequences, it is likely that other linked but as yet unidentified polymorphisms in the promoter or other regulatory elements may differentially regulate IL-12p40 expression. Thus, either there are further regulatory differences in the NOD Il12b allele or other gene(s) are responsible for the higher induced levels of IL-12 expression. In either case, finding such variants would be aided by the definition provided here of mouse Il12b alleles and would provide insights not only into the molecular regulation of IL-12p40 expression but also into how the cause of type 1 diabetes, the pathogenic Th1-type autoimmune response, is initiated.
Similarly to the genotype-based differences in IL-12 expression shown here, there are also differences in expression between human IL12B alleles; with the diabetes-susceptibility allele showing higher basal expression. 11 The lower basal expression shown by mouse strains, such as NOD/Lt, with the IL12b a allele is more reminiscent of the response associated with the IL12B 'T1D resistance' allele 2. At first this result seems paradoxical. However, an important difference between the human and mouse IL-12 system is the antagonistic activity of the IL-12p40 homodimer. Although human IL12p40 also exists in homodimeric form, it is much less efficient than mouse IL-12(p40) 2 as a competitive antagonist of IL-12 functions. 8 Therefore, the lower production of IL-12p40, both basal and after induction, may point to a decreased capacity of the NOD mouse, as well as other autoimmune-prone strains, to regulate IL-12 activity. In spite of a lower level of IL-12p40 induced after LPS administration, NOD mice produced levels of IL-12p75 similar to those attained by B6 mice, suggesting the induction of a lower amount of the potentially inhibitory p40 chain coupled with a comparable level of the biologically active IL-12 heterodimer. This would result in a net increase of IL-12 activity, consistent with the enhanced development of Th1 responses seen in NOD compared to other mouse strains. 25 There appears to be allele-specific regulation of IL12B expression in humans, but there are no common IL-12p40 isoforms. 10, 11 As shown here for the mouse, there appears to be similar allele-specific control of Il12b expression, which may show further allele-specific biological affects of IL-12 due to changes at the protein level. IL-12 is known to play a role in autoimmune diseases and other disorders. Both humans and mice appear to have genetically variable regulation of IL-12 expression; the implication that this variation in regulation may be involved in conferring susceptibility or resistance to these diseases validates the use of mouse models for developing therapies and preventative treatments targeting this important cytokine.
Materials and methods

Mice
Mice were obtained at 6-8 weeks of age from the specificpathogen free colonies of The Walter and Eliza Hall Institute of Medical Research or were purchased from Jackson Laboratories (Bar Harbour, ME, USA) and housed at the Roche Milano facility.
RT-PCR
Primer sequences used were derived from the published cDNA 3 and genomic 14 sequences corresponding to exons 1 (ie the 5′UTR) and 7; the primers were (5′ to 3′): exon1F GCACATCAGACCAGGCAGC and exon7R CATGCCC ACTTGCTGCATGA. Mice were injected i.p. with 5 g LPS and 3 h later both spleen and blood samples were obtained. Total splenic RNA was extracted with guanidinium isothiocyanate. 15 cDNA was synthesized from 2 g of total RNA using random hexamers and M-MLV-RT (Promega, Madison, WI, USA). 2% (0.5 l) of cDNA was used in a PCR reaction with the above primers, Taq DNA polymerase (Gibco BRL, Parkville, MD, USA), dNTPs (200 mM) MgCl 2 (2 mM) in a total volume of 20 ml. PCR samples were denatured at 94°C for 2 min then 35 cycles were performed at 94°C 30 s, 60°C 30 s, 72°C 120 s then 72°C 120 s. A major band of ෂ1.0 kb was identified on agarose gels and verified by hybridization with a 32 Plabelled IL-12p40 oligonucleotide probe (5′ → 3′ GTCAG GGTACTCCCAGCTGACCTCCACCTG) complementary to exon 6 sequences.
Sequence analysis
The ෂ1kb IL-12p40 RT-PCR product from NOD and C57BL/6 (B6) mice was purified and subjected to automatic sequencing using the exon1F and exon7R primers listed above with the ABI Prism BigDye Kit (PerkinElmer, Foster City, CA, USA).
ELISA measurement of IL-12p40 and IL-12p75
Individual sera were collected from mice before and after LPS injection. LPS was either from E. coli (5 mg/mouse) or Salmonella abortus equi LPS (400 g/mouse). Sera were tested for IL-12p40 levels at a dilution of 1/25 to 1/50 with the Quantikine (R&D Systems, Minneapolis, MN, USA) or OptEIA (Pharmingen) kits. Alternatively, to detect IL-12p40 the mAb used for capture was 10F6 anti-IL-12p40 followed by biotin-conjugated goat anti-IL-12, as described. 26 To detect IL-12p75 the mAb used for capture was 9A5 anti-IL-12p75 followed by 10F6-POD.
Anti-IL-12 antibodies were kindly provided by Dr MK Gately (Hoffmann-La Roche, Nutley, NJ, USA).
Characterization of exon 5/exon 7 alleles
Purified DNA was obtained from various strains and Il12b exons 5 and 7 amplified using primers from either intron 3F (5′ → 3′ CACCAGGCACTCTATCTCTGA) and exon 6R (TACTCCCAGCTGACCTCCAC) or the exon 7R primer (above) with a forward primer in intron 6 (5′ → 3′ CACCAGGCACTCTATCTCTGA). The exon 5 polymorphism was identified by direct DNA sequencing. Exon 7 alleles were typed by digestion of PCR products with HhaI (Promega).
Molecular modelling of IL-12p40 allellic forms
The protein sequences for alleles a, b and c were aligned using PSI-blast with the most significant homology being the p40 domain of human IL-12. The p40 chain of the 2.5 A crystal structure of human IL-12 27 was used as a template for the homology modelling program MODEL-LER. The alignments were adjusted by hand to ensure no insertions or deletions were placed in secondary structure elements. A family of 50 structures was produced and the resultant models checked for structural validity using the Profiles3D and ProStat modules of Homology within the InsightII molecular modelling package (Accelrys, San Diego, CA, USA). For glycosylation prediction, the protein sequences were submitted to the NetOGly 2.0 28 and the YinOYang (http://www.cbs.dtu. dk/services/YinOYang/) servers.
